Press release
Ophthalmic Drugs Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research
Global Ophthalmic Drugs Market - TechSci Research
According to TechSci Research report, “Global Ophthalmic Drugs Market By Drug Class (Anti-Inflammatory Drugs, Anti-Infection Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others) By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Others) By Product Type (OTC Drugs v/s Prescription Drugs) By Dosage Form (Gels, Ointments, Eye Solutions, Eye Drops, Tablets &Capsules) By Route of Administration (Topical, Ocular, Systemic) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) By Region, Competition Forecast & Opportunities, 2026”, the global ophthalmic drugs market may potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of rising number of patients suffering from eye diseases and vision related disorders.
Moreover, the rising number of geriatric population and their tendency to suffer from the eye diseases is further aiding the growth of the market in the next five years. Furthermore, increasing instances of cataract, glaucoma, color blindness, diabetic macular edema, cytomegalovirus retinitis, and age-related macular degeneration are also supporting the market growth.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Ophthalmic Drugs Market"
https://www.techsciresearch.com/report/ophthalmic-drugs-market/7633.html
The global ophthalmic drugs market is segmented by drug class, indication, product type, dosage form, route of administration, distribution channel, competitional landscape, and regional distribution. Based on indication, the market is further bifurcated into dry eye, eye allergy, glaucoma, eye infection, and others. Glaucoma is expected to register largest shares of the market and is anticipated to assert its dominance over the market segment on the account of increasing instances of the disease as well as the large population that is being affected. Moreover, the lifestyle choices and unhealthy food habits has aided to the ever-increasing patient count of diabetes and glaucoma therewith. The factors are intensely responsible for the growth of the market segment.
Based on product type, the market is further divided between, OTC drugs and prescription drugs. Prescription drugs have dominated the historical years and is anticipated to dominate the market in the next five years, on the account of improved safety and efficacy profiles of these drugs. OTC drugs are anticipated to register fastest growing CAGR on the backbone of advantages like easy accessibility to the patient. OTC drug market is largest in the Asia Pacific region and the demand from the region is aiding to the growth of the global market.
Market players with the prescription drugs may suffer a mild restraint due to availability of the OTC drugs. For example, the U.S. FDA has approved Alcon’s Pataday (olopatadine hydrochloride ophthalmic solution 0.7%) for OTC to treat eye allergy. Formerly, it was prescribed under the name of Pazeo. The development of this OTC ophthalmic solution is expected to increase the number of patients for Pataday's product portfolio.
Holding the major shares of the global ophthalmic drugs market are AbbVie Inc. (Allergan), Bausch Health Companies Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Hoya Corporation, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Alcon Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Merck & Co., Inc., Coherus Biosciences, Inc., among others. Market players are actively involved in the research and technological development in the pharmaceuticals and drugs department.
The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through Ophthalmic Drugs. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7633
Customers can also request for 10% free customization on this report.
“Asia Pacific is anticipated to be the most volatile and most promising market in the future five years. Anti-glaucoma and dry eye drugs are rapidly increasing in the region. Large economies like India and China are further aiding the growth of the market in the upcoming five years. Furthermore, rapidly increasing population of middle-class households along with the technological advancements in the medical infrastructures and increasing financial aids for the medical insurances is supporting the growth of the global ophthalmic drug market,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Ophthalmic Drugs Market By Drug Class (Anti-Inflammatory Drugs, Anti-Infection Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others) By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Others) By Product Type (OTC Drugs v/s Prescription Drugs) By Dosage Form (Gels, Ointments, Eye Solutions, Eye Drops, Tablets &Capsules) By Route of Administration (Topical, Ocular, Systemic) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global ophthalmic drugs and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global ophthalmic drugs market.
Browse Related Reports:
Global Rare Disease Therapeutics Market By Drug Type (Biologics, Organic Compounds) By Therapeutic Area (Cancer, Blood-related Disorders, Central Nervous System (CNS), Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Disorders, Others) By Route of Administration (Oral, Injectable, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies) By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/rare-disease-therapeutics-market/7609.html
Global Coronavirus Vaccine Market By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine and Others), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Intramuscular, Oral, Intranasal), By Patient Type (Adults v/s Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/coronavirus-vaccine-market/4694.html
About TechSci Research:
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ophthalmic Drugs Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research here
News-ID: 2345579 • Views: …
More Releases from TechSci Research Pvt Ltd
India AI in Medical Diagnostics Market Future Outlook (2024-2030)
India AI in Medical Diagnostics Market Outlook
The India AI in Medical Diagnostics Market, valued at USD 12.87 million in 2024, is poised for significant growth, with a projected compound annual growth rate (CAGR) of 23.10% from 2020 to 2030, reaching an estimated USD 44.87 million by 2030. This robust expansion is driven by the increasing adoption of artificial intelligence (AI) solutions in healthcare, a rising demand for early and accurate…
The Future of Robotic Healthcare Market in India
India Surgical Robotics Market Outlook
The India Surgical Robotics Market, valued at USD 24.72 million in 2024, is on a trajectory of significant growth, projected to reach USD 44.91 million by 2030, driven by a robust compound annual growth rate (CAGR) of 10.42%. This expansion is underpinned by a confluence of factors, including the rising demand for minimally invasive surgeries, advancements in robotic technologies, and the rapid development of healthcare infrastructure…
India Medical Lasers Market: Growth, Trends, and Challenges (2020-2030)
The India Medical Lasers Market is poised for significant growth, projected to expand at a compound annual growth rate (CAGR) of 12.90%, rising from USD 31.20 million in 2024 to USD 64.75 million by 2030. This robust growth is driven by increasing demand for minimally invasive procedures, a rising prevalence of chronic diseases, and supportive government initiatives such as Ayushman Bharat and Make in India. These programs are enhancing healthcare…
India Pneumococcal Vaccine Market Report Outlook 2030 by TechSci Research
Market Outlook: India Pneumococcal Vaccine Market
The India pneumococcal vaccine market is projected to grow from USD 32.52 million in 2024 to USD 48.67 million by 2030, reflecting a CAGR of 6.91%. Growth is being driven by strong government initiatives, such as the inclusion of the Pneumococcal Conjugate Vaccine (PCV) in the Universal Immunization Programme (UIP), rising awareness about pneumonia-related mortality-especially in children-and enhanced local production by domestic manufacturers.
Support from international…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
